Pharming Group N.V. Sponsored ADR (PHAR)

Last Closing Price: 9.33 (2024-04-18)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pharming Group N.V. Sponsored ADR (PHAR) had Revenue of $66.70M for the most recently reported fiscal quarter, ending 2023-09-30.

Figures for fiscal quarter ending 2023-09-30
Income Statement Financials
Revenue
$66.70M
$3.50M
$8.30M
$58.40M
$64.80M
$1.90M
$1.40M
$3.30M
$3.30M
$3.50M
$3.50M
$3.50M
$3.50M
$1.90M
$1.90M
70.00M
70.00M
$0.05
$0.05
Balance Sheet Financials
$291.74M
$9.65M
$144.73M
$436.47M
$68.06M
$129.73M
$158.47M
$226.53M
$209.94M
$140.09M
$209.94M
--
Cash Flow Statement Financials
$-28.88M
$-125.48M
$-0.02M
$207.34M
$54.65M
$-152.69M
$5.93M
--
--
Fundamental Metrics & Ratios
4.29
--
--
0.38
0.63
87.56%
2.85%
2.85%
--
4.95%
5.25%
$-30.01M
--
--
--
0.15
0.16
1.65
54.68
1.67%
2.50%
0.80%
1.03%
--
$-0.43
$-0.41